1887 related articles for article (PubMed ID: 27852330)
1. Appearance of claudin-5
Paul D; Baena V; Ge S; Jiang X; Jellison ER; Kiprono T; Agalliu D; Pachter JS
J Neuroinflammation; 2016 Nov; 13(1):292. PubMed ID: 27852330
[TBL] [Abstract][Full Text] [Related]
2. Appearance of claudin-5
Krajewski D; Paul D; Ge S; Jellison E; Pachter JS
J Neuroinflammation; 2021 Dec; 18(1):296. PubMed ID: 34933669
[TBL] [Abstract][Full Text] [Related]
3. Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
Paul D; Cowan AE; Ge S; Pachter JS
Microvasc Res; 2013 Mar; 86():1-10. PubMed ID: 23261753
[TBL] [Abstract][Full Text] [Related]
4. Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation.
Paul D; Ge S; Lemire Y; Jellison ER; Serwanski DR; Ruddle NH; Pachter JS
J Neuroinflammation; 2014 Jan; 11():10. PubMed ID: 24444311
[TBL] [Abstract][Full Text] [Related]
5. CD99L2 deficiency inhibits leukocyte entry into the central nervous system and ameliorates neuroinflammation.
Samus M; Seelige R; Schäfer K; Sorokin L; Vestweber D
J Leukoc Biol; 2018 Oct; 104(4):787-797. PubMed ID: 29791026
[TBL] [Abstract][Full Text] [Related]
6. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
[TBL] [Abstract][Full Text] [Related]
7. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
8. Artesunate Ameliorates Experimental Autoimmune Encephalomyelitis by Inhibiting Leukocyte Migration to the Central Nervous System.
Thomé R; de Carvalho AC; Alves da Costa T; Ishikawa LL; Fraga-Silva TF; Sartori A; de Oliveira AL; Verinaud L
CNS Neurosci Ther; 2016 Aug; 22(8):707-14. PubMed ID: 27165523
[TBL] [Abstract][Full Text] [Related]
9. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
[TBL] [Abstract][Full Text] [Related]
10. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
Tietz SM; Engelhardt B
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
[TBL] [Abstract][Full Text] [Related]
11. Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus.
Breuer J; Korpos E; Hannocks MJ; Schneider-Hohendorf T; Song J; Zondler L; Herich S; Flanagan K; Korn T; Zarbock A; Kuhlmann T; Sorokin L; Wiendl H; Schwab N
J Neuroinflammation; 2018 Aug; 15(1):236. PubMed ID: 30134924
[TBL] [Abstract][Full Text] [Related]
12. Extracellular vesicles from human umbilical cord blood plasma modulate interleukin-2 signaling of T cells to ameliorate experimental autoimmune encephalomyelitis.
Kim S; Maeng JY; Hyun SJ; Sohn HJ; Kim SY; Hong CH; Kim TG
Theranostics; 2020; 10(11):5011-5028. PubMed ID: 32308765
[TBL] [Abstract][Full Text] [Related]
13. Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Ingwersen J; Wingerath B; Graf J; Lepka K; Hofrichter M; Schröter F; Wedekind F; Bauer A; Schrader J; Hartung HP; Prozorovski T; Aktas O
J Neuroinflammation; 2016 Feb; 13():48. PubMed ID: 26920550
[TBL] [Abstract][Full Text] [Related]
14. Kinin B2 receptor regulates chemokines CCL2 and CCL5 expression and modulates leukocyte recruitment and pathology in experimental autoimmune encephalomyelitis (EAE) in mice.
Dos Santos AC; Roffê E; Arantes RM; Juliano L; Pesquero JL; Pesquero JB; Bader M; Teixeira MM; Carvalho-Tavares J
J Neuroinflammation; 2008 Nov; 5():49. PubMed ID: 18986535
[TBL] [Abstract][Full Text] [Related]
15. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme.
Wolburg H; Wolburg-Buchholz K; Kraus J; Rascher-Eggstein G; Liebner S; Hamm S; Duffner F; Grote EH; Risau W; Engelhardt B
Acta Neuropathol; 2003 Jun; 105(6):586-92. PubMed ID: 12734665
[TBL] [Abstract][Full Text] [Related]
16. E- and P-selectin are not required for the development of experimental autoimmune encephalomyelitis in C57BL/6 and SJL mice.
Döring A; Wild M; Vestweber D; Deutsch U; Engelhardt B
J Immunol; 2007 Dec; 179(12):8470-9. PubMed ID: 18056394
[TBL] [Abstract][Full Text] [Related]
17. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
[TBL] [Abstract][Full Text] [Related]
18. Astrocytes play a key role in EAE pathophysiology by orchestrating in the CNS the inflammatory response of resident and peripheral immune cells and by suppressing remyelination.
Brambilla R; Morton PD; Ashbaugh JJ; Karmally S; Lambertsen KL; Bethea JR
Glia; 2014 Mar; 62(3):452-67. PubMed ID: 24357067
[TBL] [Abstract][Full Text] [Related]
19. Erythropoietin reduces experimental autoimmune encephalomyelitis severity via neuroprotective mechanisms.
Moransard M; Bednar M; Frei K; Gassmann M; Ogunshola OO
J Neuroinflammation; 2017 Oct; 14(1):202. PubMed ID: 29029628
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.
Bozoyan L; Dumas A; Patenaude A; Vallières L
J Neuroinflammation; 2015 Sep; 12():173. PubMed ID: 26377915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]